Opaganib demonstrated potent antiviral activity against SARS-CoV-2, completely inhibiting viral replication in an in vitro model of human lung bronchial tissue. ... Oct 22
Protagonist Therapeutics has previously received orphan drug designation for the treatment of polycythemia vera from US FDA... Oct 22
Under this agreement, Samsung and Dinona will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy... Oct 22
A new focus is on consulting services for the transition of products from the development phase to the GMP compliant manufacturing of investigational medicinal products... Oct 22
The merger will enable the two companies to take full advantage of growing industry opportunities and more effectively address industry challenges... Oct 22
-Advertisements-